MHRA Alert – December 2024 Medicine Recalls and Safety Letters

Important Safety Update from the MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a summary of letters and notifications issued to healthcare professionals during December 2024 concerning medicines and medical devices. This update consolidates recent safety communications to help you stay informed of regulatory actions affecting your practice.

What You Need to Know

The MHRA regularly issues safety alerts, recalls, and regulatory letters to ensure patient safety and maintain the integrity of the medicines supply chain. December's communications covered a range of issues including product recalls, safety updates, and supply notifications.

Key Actions for Healthcare Professionals

• Review the full alert on the MHRA website to identify any medicines or devices used in your setting
• Check your current stock against any recalled batches or products listed
• Ensure your team is aware of any label changes or new safety information
• Follow local protocols for handling affected medicines or devices
• Report any adverse events or product defects to the MHRA Yellow Card scheme

Staying Updated

We recommend subscribing to MHRA safety updates directly or checking the regulatory alerts section of First Responder regularly. Timely awareness of these communications is essential for maintaining safe clinical practice.

Further Information

For the complete list of December 2024 recalls and safety letters, visit the MHRA drug safety update page.